Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil treatment

被引：0
|
作者：
T. Darreh-Shori
L. Meurling
T. Pettersson
K. Hugosson
E. Hellström-Lindahl
N. Andreasen
L. Minthon
A. Nordberg
机构：
[1] Karolinska University Hospital Huddinge,Division of Molecular Neuropharmacology, Department of Neurobiology, Care Sciences and Society, Karolinska Institute
[2] Karolinska University Hospital Huddinge,Department of Geriatric Medicine
[3] Karolinska University Hospital Huddinge,Labmedicin, Division for Clinical Pharmacology
[4] University Hospital MAS,Neuropsychiatric Clinic
来源：
Journal of Neural Transmission | 2006年 / 113卷
关键词：
Keywords: Alzheimer’s disease, acetylcholinesterase, acetylcholinesterase splice variants, cholinesterase inhibitors, cerebrospinal fluid (CSF), red blood cells (RBC), chronic treatment, donepezil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives. To evaluate long-term changes in acetylcholinesterase (AChE) activity in CSF and blood following donepezil treatment in relation to the concentration of donepezil and cognition in AD patients.
引用
收藏
页码：1791 / 1801
页数：10
相关论文
共 50 条
  • [1] Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment
    Darreh-Shori, T.
    Meurling, L.
    Pettersson, T.
    Hugosson, K.
    Hellstrom-Lindahl, E.
    Andreasen, N.
    Minthon, L.
    Nordberg, A.
    JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (11) : 1791 - 1801
  • [2] CSF levels of total tau protein in patients with mild cognitive impairment and Alzheimer's disease
    Kaiser, E.
    Schoenknecht, P.
    Hunt, A.
    Thomann, P. A.
    Pantel, J.
    Schroeder, J.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2008, 41 (06): : 497 - 501
  • [3] Donepezil treatment improves cognitive performance in patients with very mild Alzheimer's disease
    Seltzer, B
    Zolnouni, P
    Nunez, M
    Goldman, R
    Noble, Y
    Kumar, D
    Griesing, T
    Richardson, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S385 - S385
  • [4] Enhanced CBF Changes by Donepezil Treatment Correlate with Cognitive Improvement in Mild Alzheimer's Disease
    Antuono, Piero
    Jones, Jennifer
    Xie, Chunming
    Li, Wenjun
    Wu, Zhilin
    McRae, Thomas
    Li, Shi-Jiang
    NEUROLOGY, 2009, 72 (11) : A148 - A148
  • [5] Sustained cognitive improvement following treatment of Alzheimer's disease with donepezil
    Evans, M
    Ellis, A
    Watson, D
    Chowdhury, T
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (01) : 50 - 53
  • [6] ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease
    He, M.
    Ohrui, T.
    Maruyama, M.
    Tomita, N.
    Nakayama, K.
    Higuchi, M.
    Furukawa, K.
    Arai, H.
    NEUROLOGY, 2006, 67 (07) : 1309 - 1310
  • [7] Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
    Yiannopoulou, Konstantina G.
    Anastasiou, Aikaterini I.
    Kyrozis, Andreas
    Anastasiou, Ioannis P.
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 126 - 136
  • [8] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166
  • [9] Assessment of CSF levels of tan protein in patients with Alzheimer's disease and mild dementia - Reply
    Galasko, D
    NEUROLOGY, 1997, 49 (06) : 1753 - 1753
  • [10] Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease
    Doody, RS
    Dunn, JK
    Clark, CM
    Farlow, M
    Foster, NL
    Liao, T
    Gonzales, N
    Lai, E
    Massman, P
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (04) : 295 - 300
12345